Troy Edward Wilson, President and CEO: Kura Oncology KURA Sell · Filed 25/09/29

Trade details

Type: Insider sale
Amount: $327,338.1
Shares · price: 36,615 sh · $8.94 a share
Held after: 246,853 sh
Stock: Kura Oncology KURA
Person: Troy Edward WilsonPresident and CEO
Trade date: 25/09/29
Filed: 25/09/29
Days to filing: 0 days

Sold 12.9% of holdings

Share of holding sold: 12.9%

Kura Oncology trades, last 26 weeks

What else happened in Kura Oncology around then

Filed or reported within 30 days of the trade day · 25/08/30~25/10/29

Troy Edward Wilson's recent trades

Troy Edward WilsonDirector
Planned sale10b5-1 planPuma Biotechnology
Planned sale10b5-1 plan
Puma Biotechnology
PBYI
$45.5K
5,000 sh
$45.5K
Filed 09/14
Traded 09/14
Troy Edward WilsonDirector
Sell10b5-1 planPuma Biotechnology
Sell10b5-1 plan
Puma Biotechnology
PBYI
$77.8K
10,800 sh
$77.8K
Filed 06/15
Traded 06/12
Troy Edward WilsonDirector
Planned sale10b5-1 planPuma Biotechnology
Planned sale10b5-1 plan
Puma Biotechnology
PBYI
$78.4K
10,800 sh
$78.4K
Filed 06/12
Traded 06/12
Troy Edward WilsonOfficer, Director
Planned saleKura Oncology
Planned sale
Kura Oncology
KURA
$331.4K
36,615 sh
$331.4K
Filed 25/09/29
Traded 25/09/29
Troy Edward WilsonDirector
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$750K
15,000 sh
$750K
Filed 25/09/09
Traded 25/09/05

Troy Edward Wilson, CEO — sold $327.3K of Kura Oncology KURA · 12.9% of holdings | Whalegun